Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

Clinical trial NCT00532246 · COMPLETED

Trial details

NCT number: NCT00532246
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Osteoporosis, Post-Menopausal

Start date: 2003-03-01
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.